Guardion Health Sciences Inc
NASDAQ:GHSI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its Industry Average (4.5), the stock would be worth $-3.93 (222% downside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -3.7 | $3.22 |
0%
|
| Industry Average | 4.5 | $-3.93 |
-222%
|
| Country Average | 6.5 | $-5.66 |
-276%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Guardion Health Sciences Inc
NASDAQ:GHSI
|
4.1m USD | -3.7 | 0.6 | |
| FR |
|
L'Oreal SA
PAR:OR
|
195.4B EUR | 6 | 31.9 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
96.1B GBP | 5.6 | 11.7 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.3T INR | 15.7 | 36.4 | |
| UK |
|
HALEON PLC
LSE:HLN
|
30.6B GBP | 5.2 | 18.4 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28.7B USD | 3 | -161.1 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.5B EUR | 2.3 | 16.5 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 3.7 | 22.1 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 13.9 | 59.9 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | 4 939.9 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
783.1B INR | 11.9 | 42.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 4.2 |
| Median | 6.5 |
| 70th Percentile | 10.6 |
| Max | 1 764 211.7 |
Other Multiples
Guardion Health Sciences Inc
Glance View
Guardion Health Sciences, Inc.is a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provide supportive health benefits to consumers. The company is headquartered in Houston, Texas and currently employs 13 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products and devices designed to support healthcare professionals and providers, and their patients and consumers. The Company, through Activ Nutritional, LLC (Activ), owns the Viactiv line of supplement chews for bone health, immune health, and other applications. The Viactiv line of supplements contains several flavored nutritional supplement products, but the milk chocolate and caramel-flavored calcium chews constitute the main product category. The company also sells Lumega-Z, its medical food product that has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. The firm's GlaucoCetin, a medical food, which offers a formula that is designed to support proper mitochondrial function in the optic nerve cells in glaucoma patients.
